Endo Pharmaceuticals has officially withdrawn Opana ER from the market at the FDA’s request. The extended release opioid medication recently became the subject of an inquiry by the agency because of the specific way it was being abused.
Opana ER was designed to slowly and steadily medicate a patient as an extended release medication. However, when crushed, snorted, or injected, an abuser can get the full dose ...
continue reading...
A story in the Huffington Post says that a Medicare program meant to provide medications for the elderly and disabled is subject to widespread abuse.
An analysis by public advocacy journalism Website ProPublica found that that healthcare professionals throughout the country are prescribing large quantities of drugs under the program that are potentially harmful or addictive, and that the federal officials charged with overseeing the program have done little to curb ...
continue reading...
